title: Nephrotoxicity of recent anti-cancer agents.
abstract: Cancer patients may develop a variety of kidney lesions that impair not only their immediate survival but also limit the adequate treatment of the underlying malignant process. This review summarizes the nephrotoxic potential of some of the most recently developed anti-cancer drugs, focusing on those interfering with the vascular endothelial growth factor and epidermal growth factor receptor pathways and mammalian target of rapamycin inhibitors. Thrombotic microangiopathy (haemolytic-uraemic syndrome), proteinuria, hypertension and magnesium depletion are the most common side effects. Also the risk for developing acute kidney injury in patients with advanced prostate cancer undergoing androgen deprivation therapy is discussed.
authors: University Hospital , 185, De Pintelaan, Gent 9000 , Belgium.
authors: Norbert
authors: N
authors: Lameire
keywords: androgen deprivation therapy and AKI; anti-angiogenesis drugs and cancer; anti-cancer drugs and nephrotoxicity